Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study identified a 4.8% prevalence of androgenetic alopecia among Nigerian females, and found that the condition tends to be severe with specific trichoscopic features.

This study reported that androgenetic alopecia is relatively uncommon but severe among Nigerian females, with a prevalence of 4.8% among urban market traders.

In this hospital-based cross-sectional study, researchers observed that trichoscopy effectively differentiates between severe and mild male pattern hair loss by identifying specific features such as yellow and white dots, vellus hair, and hair shaft diversity.

This study found that platelet-rich plasma therapy was more effective in increasing hair count than topical 5% minoxidil lotion in men with androgenetic alopecia.

No link found between hair loss severity and PSA levels in men.

In this study, the authors reported no significant difference in sexual dysfunction between finasteride users and non-users among men with androgenetic alopecia, suggesting that finasteride does not cause sexual dysfunction. This finding aligns with other large survey-based studies.

This study found no correlation between serum PSA levels and the severity of androgenetic alopecia at baseline in men.

This study found that metabolic syndrome was significantly more common in men with early-onset androgenetic alopecia compared to controls, indicating a potential increased risk of cardiovascular issues in this population.

In this study, platelet rich plasma treatment showed efficacy in improving hair count, thickness, and density in male patients with androgenetic alopecia.

In this study, topical minoxidil significantly improved the quality of life for females with androgenic alopecia, as measured by both the dermatology life quality index and a visual analog scale.

In this study, a woman's hair loss and physical condition reportedly improved with pharmacopuncture and needle-embedding therapy, but further research is suggested to validate these findings.

This study found that both finasteride and low level laser therapy were similarly effective in improving hair regrowth for frontal pattern hair loss in men and women over a 3-month period.

This study reported that using condensed nanofat combined with fat grafts significantly improved the aesthetic and functional aspects of atrophic facial scars in 20 patients, as assessed by both patients and plastic surgeons using the Patient and Observer Scar Assessment Scale.

This study reported that enoxaparin may cause alopecia in patients treated for cerebral venous thrombosis, with hair growth resuming naturally after the treatment ended.

Wigs significantly improve the well-being of people with severe hair loss.

This case series found that low-frequency repetitive transcranial magnetic stimulation may benefit some patients with trichotillomania, although one of five patients experienced worsening symptoms after treatment.

This case report describes an atypical postfinasteride syndrome in a patient treated with both dutasteride and finasteride for androgenic alopecia, highlighting its multisystem involvement and irreversible nature.

This case report describes an 11-year-old girl who experienced hot flashes and menarche after taking a Serenoa repens supplement for telogen effluvium, suggesting a possible but uncertain link between the supplement and hormonal changes.

This case report describes a 35-year-old man who developed an atypical DRESS syndrome after taking topiramate for migraine prevention, which resolved with drug withdrawal and symptomatic treatment.

This letter reports on the impact wigs may have on the perceived quality of life in patients with androgenetic alopecia.

This study found that applying minced residual skin grafts to donor sites significantly reduced healing time and improved scar quality compared to untreated sites.

This letter to the editor reports no new results but discusses the effect of hairpieces on the perceived quality of life in female pattern hair loss patients.

This case report describes the first known instance of hair loss linked to agomelatine, which resolved after the drug was discontinued.

This study found that bupropion SR may improve symptoms in female trichotillomania patients who did not respond to SSRIs, with benefits maintained through a 16-month follow-up.

In this case report, a 14-year-old girl developed azathioprine-induced anagen effluvium, highlighting it as a rare but reversible side effect with prompt drug withdrawal leading to significant hair regrowth.

This case report describes a rare instance of gynecomastia in a male patient undergoing mirtazapine treatment for depression, suggesting the drug as a probable cause after ruling out other factors.

This study found that the Severity of Alopecia Tool score does not predict the quality of life in patients with alopecia areata, suggesting patient-reported outcomes better reflect the impact on life quality.

The antidepressant escitalopram likely caused hair loss in a patient.

In this study, a combination of low-dose minoxidil 0.25 mg and spironolactone 25 mg reduced hair shedding and improved hair density in patients with female pattern hair loss, with mild adverse effects.

This review discusses trichotillomania and traction alopecia, focusing on their clinical features, diagnostic criteria, and treatment options, but it reports no new research findings.